Peakdata

PeakData is a Swiss-based technology company founded in 2018 that specializes in delivering AI-powered insights and analytics to the pharmaceutical industry. The company’s core mission is to help pharma organizations better understand and engage with healthcare professionals (HCPs) by leveraging big data and artificial intelligence. Through its proprietary platform, PeakData aggregates and analyzes vast amounts of publicly available online information to build dynamic, ranked profiles of HCPs. These profiles include data on physicians’ research interests, digital activity, clinical influence, and peer networks, enabling pharmaceutical teams to make more informed decisions about targeting, segmentation, and engagement strategies. By offering real-time updates and actionable intelligence, PeakData empowers companies to adapt their go-to-market approaches and optimize the adoption of medical treatments. The platform is designed to support a wide range of use cases across medical affairs, marketing, and sales functions. It facilitates agile segmentation and targeting by identifying the most relevant experts in specific therapeutic areas, helping teams prioritize outreach based on influence and relevance. Expert mapping and profiling tools allow users to visualize the relationships and networks among HCPs, uncovering key opinion leaders and digital influencers who can amplify messaging and drive awareness. Additionally, PeakData’s digital activators feature enables companies to track and engage with HCPs who are active online, while its impact tracking capabilities provide insights into the effectiveness of engagement efforts over time. These features are particularly valuable in today’s fast-evolving healthcare landscape, where digital communication and data-driven strategies are increasingly critical to success. PeakData’s leadership team brings together deep expertise in data science, software engineering, and healthcare. The company’s founder, Patrick, previously served as CTO at the Center for Collective Intelligence at MIT, where he developed platforms for global climate action adopted by major institutions like the US White House and the UN Paris Climate Accord. His scientific background and passion for sustainability inform PeakData’s culture of innovation and purpose-driven technology. Other key executives include Rob, an experienced investor in pharma services technology and former founder of STEM Healthcare, and Andy, a veteran of Novartis and STEM Healthcare with over two decades of experience in pharmaceutical commercial roles. Together, they have built a company that combines technical excellence with a deep understanding of the healthcare ecosystem. Financially, PeakData has attracted significant venture capital backing, completing multiple funding rounds including a Series B in August 2024. The company has raised millions in capital from investors such as AlbionVC, Octopus Ventures, and HEMEX, reflecting strong confidence in its growth potential and market relevance. With a team of over 50 employees and a presence in Switzerland and Germany, PeakData continues to expand its footprint across Europe and beyond. Its SaaS-based model and scalable architecture make it well-suited to serve global pharmaceutical clients, including more than half of the top 20 pharma companies who rely on its platform for strategic decision-making. In an industry where timely and accurate insights can significantly impact patient outcomes and commercial success, PeakData stands out as a transformative force. By bridging the gap between data and action, it enables pharmaceutical companies to navigate complex therapeutic landscapes with greater agility and precision. Its commitment to improving patient care through smarter engagement and its ability to deliver real-world value through technology have positioned PeakData as a leader in healthcare analytics. As the demand for personalized medicine and digital transformation continues to grow, PeakData is poised to play an increasingly vital role in shaping the future of pharma-HCP interactions.

PeakData’s competitive edge lies in its ability to deliver highly granular, real-time insights into healthcare professionals (HCPs) using advanced artificial intelligence and big data analytics. Unlike many of its competitors, PeakData doesn’t rely solely on static databases or traditional CRM systems. Instead, it continuously mines publicly available online data to build dynamic, ranked profiles of HCPs, capturing their digital activity, research interests, and clinical influence. This allows pharmaceutical companies to identify not just established key opinion leaders (KOLs), but also emerging voices and digital influencers who are shaping conversations in specific therapeutic areas. The platform’s agility and precision in mapping the healthcare universe—reportedly up to 90% coverage—gives it a distinct advantage in helping pharma teams adapt their targeting and engagement strategies with speed and accuracy. Another key differentiator is PeakData’s suite of specialized tools tailored to the needs of medical affairs, marketing, and sales teams. Its expert mapping and profiling capabilities go beyond simple contact lists, offering visualizations of peer-to-peer networks and influence pathways. This enables companies to uncover hidden connections and leverage them for more effective outreach. The platform’s digital activators feature is particularly valuable in today’s increasingly virtual healthcare environment, allowing users to track and engage with HCPs who are active online. Moreover, PeakData’s impact tracking tools provide feedback on the effectiveness of engagement efforts, helping teams refine their messaging and measure ROI. These features are not only technologically advanced but also strategically aligned with the evolving demands of the pharmaceutical industry. PeakData also benefits from a strong leadership team with deep expertise in both technology and healthcare. Its founder’s background in collective intelligence and global platforms, combined with the commercial experience of executives from companies like Novartis and STEM Healthcare, ensures that the platform is both innovative and grounded in real-world pharma needs. Financial backing from reputable investors such as AlbionVC, Octopus Ventures, and HEMEX further reinforces its credibility and growth potential. While competitors like Komodo Health and Clarify offer robust analytics platforms, PeakData’s unique blend of real-time data mining, AI-driven profiling, and strategic engagement tools positions it as a standout solution in the crowded healthcare analytics space.

• Small Businesses (1-99)
• Mid Market (100-500)
• Enterprise (500+)